About the company
Boston Scientific, a leading medical device company headquartered in Marlborough, Massachusetts, is at the forefront of innovation in the healthcare industry. With a primary focus on developing and producing minimally invasive medical devices, the company has revolutionized the way various medical conditions are diagnosed and treated. One of the key strengths of Boston Scientific lies in its expertise in creating devices that can be inserted into the human body through small openings or cuts. This minimally invasive approach allows for quicker recovery times, reduced scarring, and lower risks compared to traditional open surgeries. By constantly pushing the boundaries of medical technology, the company has successfully transformed patient care and improved clinical outcomes. Boston Scientific's product portfolio encompasses a wide range of medical specialties. In the field of interventional cardiology, the company offers devices used in angioplasty procedures, which enable the reopening of narrowed or blocked blood vessels. Additionally, Boston Scientific manufactures blood clot filtration systems that help prevent potentially life-threatening pulmonary embolisms. The firm's expertise also extends to cardiac rhythm management. Its innovative implantable devices, such as pacemakers and defibrillators, help regulate and restore optimal heart function in patients with arrhythmias or other cardiac conditions. Furthermore, Boston Scientific is a pioneer in developing catheter-directed ultrasound imaging technologies, allowing physicians to visualize and diagnose potential cardiovascular issues with greater precision. In recent years, Boston Scientific has also made significant contributions to the field of gastroenterology. With its advanced upper gastrointestinal tract diagnostic tools, doctors can detect and assess conditions such as Barrett's esophagus and early-stage gastrointestinal cancers more accurately. This early detection greatly improves treatment options and patient outcomes. The company's commitment to innovation extends beyond cardiovascular and gastrointestinal care. Boston Scientific is actively involved in the field of interventional oncology, developing cutting-edge technologies that enable targeted treatment of tumors and metastases. These minimally invasive procedures reduce patient discomfort and enhance the efficacy of cancer therapies. Boston Scientific's dedication to improving the quality of life for patients is evident in its development of neuromodulation technologies for chronic pain management. By utilizing implanted devices that deliver electrical signals to the nervous system, these state-of-the-art technologies offer much-needed relief for individuals suffering from chronic pain conditions. Another area where Boston Scientific has made significant advancements is the treatment of urinary incontinence. With its range of products, including implantable devices and minimally invasive surgical techniques, the company provides effective solutions that improve the quality of life for millions of patients worldwide. Throughout its operations, Boston Scientific maintains a global presence. The company actively markets its devices to healthcare professionals and institutions around the world, contributing to its substantial foreign sales, which account for nearly half of the total sales revenue. This global reach allows Boston Scientific to impact healthcare systems on a global scale, improving patient care and outcomes across different regions. In conclusion, Boston Scientific's relentless dedication to producing less invasive medical devices has transformed the way healthcare professionals diagnose and treat a range of medical conditions. Through its extensive portfolio of innovative products, the company continues to improve patient outcomes, reduce pain, and enhance quality of life for individuals around the world. With its global presence and commitment to innovation, Boston Scientific remains at the forefront of medical technology advancement, shaping the future of healthcare.
Website: https://www.bostonscientific.com
Data updated: June 2, 2026
